# clm_B19E42064034

subject: Abbott Laboratories (/record/abbott-laboratories.md)  
predicate: quarterly_revenue  
value: 10,358,000,000 United States dollar  
valid_from: 2025-03-31  
valid_to: 2025-06-30  
published: 2025-04-30  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_E9EFA461ED0C  
last_updated: 2026-11-08  
cite: AsOf. "Abbott Laboratories quarterly revenue: 10,358,000,000 United States dollar", as of 2025-03-31 (until 2025-06-30). Claim clm_B19E42064034, https://asof.is/claim/clm_B19E42064034, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1800/000162828025021090/0001628280-25-021090-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2025, filed 2025-04-30  

## Sources

- https://www.sec.gov/Archives/edgar/data/1800/000162828025021090/0001628280-25-021090-index.htm (primary, SEC EDGAR 10-Q Q1 FY2025, published 2025-04-30)

## Supersedes

- [Abbott Laboratories](/record/abbott-laboratories.md) | quarterly_revenue | 10,635,000,000 United States dollar | valid 2024-09-30 to 2025-03-31 | conf 0.95 | superseded | superseded_by [clm_B19E42064034](/claim/clm_B19E42064034.md) | [clm_12D7EF8B99CE](/claim/clm_12D7EF8B99CE.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.